The DOI matches its Crossref record; 262 of the 262 references it cites were found in a registry or an index.
Natural Products for Drug Discovery in the 21st Century: Innovations for Novel Drug Discovery
Open accessAbstract
The therapeutic properties of plants have been recognised since time immemorial. Many pathological conditions have been treated using plant-derived medicines. These medicines are used as concoctions or concentrated plant extracts without isolation of active compounds. Modern medicine however, requires the isolation and purification of one or two active compounds. There are however a lot of global health challenges with diseases such as cancer, degenerative diseases, HIV/AIDS and diabetes, of which modern medicine is struggling to provide cures. Many times the isolation of “active compound” has made the compound ineffective. Drug discovery is a multidimensional problem requiring several parameters of both natural and synthetic compounds such as safety, pharmacokinetics and efficacy to be evaluated during drug candidate selection. The advent of latest technologies that enhance drug design hypotheses such as Artificial Intelligence, the use of ‘organ-on chip’ and microfluidics technologies, means that automation has become part of drug discovery. This has resulted in increased speed in drug discovery and evaluation of the safety, pharmacokinetics and efficacy of candidate compounds whilst allowing novel ways of drug design and synthesis based on natural compounds. Recent advances in analytical and computational techniques have opened new avenues to process complex natural products and to use their structures to derive new and innovative drugs. Indeed, we are in the era of computational molecular design, as applied to natural products. Predictive computational softwares have contributed to the discovery of molecular targets of natural products and their derivatives. In future the use of quantum computing, computational softwares and databases in modelling molecular interactions and predicting features and parameters needed for drug development, such as pharmacokinetic and pharmacodynamics, will result in few false positive leads in drug development. This review discusses plant-based natural product drug discovery and how innovative technologies play a role in next-generation drug discovery.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Newmaster, S. G., Grguric, M., Shanmughanandhan, D., Ramalingam, S., & Ragupathy, S. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-222 · Cited by 484
RetractedThompson, K. A., & Newmaster, S. G. (2014) · Biodiversity and Conservation · doi:10.1007/s10531-014-0672-z · Cited by 39
RetractedLeCun, Y., Bengio, Y., & Hinton, G. (2015) · Nature · doi:10.1038/nature14539 · Cited by 84,126
Lamb, J., Crawford, E. D., Peck, D., Modell, J. W., Blat, I. C., Wrobel, M. J., Lerner, J., Brunet, J.-P., Subramanian, A., Ross, K. N., et al. (2006) · Science · doi:10.1126/science.1132939 · Cited by 5,257
Genome-scale CRISPR-Cas9 knockout screening in human cells
Shalem, O., Sanjana, N. E., Hartenian, E., Shi, X., Scott, D. A., Mikkelsen, T. S., Heckl, D., Ebert, B. L., Root, D. E., Doench, J. G., et al. (2014) · Science · doi:10.1126/science.1247005 · Cited by 5,234
Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
The Cancer Genome Atlas Research Network (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1301689 · Cited by 5,078
Faulkner, D. J. (1990) · Natural Product Reports · doi:10.1039/np9900700269 · Cited by 4,866
Natural products as sources of new drugs over the 30 years from 1981 to 2010
Newman, D. J., & Cragg, G. M. (2012) · Journal of Natural Products · doi:10.1021/np200906s · Cited by 4,687
ChEMBL: a large-scale bioactivity database for drug discovery
Gaulton, A., Bellis, L. J., Bento, A. P., Chambers, J., Davies, M., Hersey, A., Light, Y., McGlinchey, S., Michalovich, D., Al-Lazikani, B., et al. (2012) · Nucleic Acids Research · doi:10.1093/nar/gkr777 · Cited by 4,382
Wani, M. C., Taylor, H. L., Wall, M. E., Coggon, P., & McPhail, A. T. (1971) · Journal of the American Chemical Society · doi:10.1021/ja00738a045 · Cited by 4,073
Drug-like properties and the causes of poor solubility and poor permeability
Lipinski, C. A. (2000) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/s1056-8719(00)00107-6 · Cited by 3,734
Detecting Novel Associations in Large Data Sets
Reshef, D. N., Reshef, Y. A., Finucane, H. K., Grossman, S. R., McVean, G., Turnbaugh, P. J., Lander, E. S., Mitzenmacher, M., & Sabeti, P. C. (2011) · Science · doi:10.1126/science.1205438 · Cited by 3,339
Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas
The Cancer Genome Atlas Research Network (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1402121 · Cited by 3,148
The re-emergence of natural products for drug discovery in the genomics era
Harvey, A. L., Edrada-Ebel, R., & Quinn, R. J. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4510 · Cited by 2,572
Target-Oriented and Diversity-Oriented Organic Synthesis in Drug Discovery
Schreiber, S. L. (2000) · Science · doi:10.1126/science.287.5460.1964 · Cited by 2,568
Clinical development success rates for investigational drugs
Hay, M., Thomas, D. W., Craighead, J. L., Economides, C., & Rosenthal, J. (2014) · Nature Biotechnology · doi:10.1038/nbt.2786 · Cited by 2,536
Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast Cancer
Baselga, J., Cortés, J., Kim, S.-B., Im, S.-A., Hegg, R., Im, Y.-H., Roman, L., Pedrini, J. L., Pienkowski, T., Knott, A., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1113216 · Cited by 2,532
The Traditional Medicine and Modern Medicine from Natural Products
Yuan, H., Ma, Q., Ye, L., & Piao, G. (2016) · Molecules · doi:10.3390/molecules21050559 · Cited by 2,434
Gaulton, A., Hersey, A., Nowotka, M., Bento, A. P., Chambers, J., Mendez, D., Mutowo, P., Atkinson, F., Bellis, L. J., Cibrián-Uhalte, E., et al. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkw1074 · Cited by 2,330
Monitoring Drug Target Engagement in Cells and Tissues Using the Cellular Thermal Shift Assay
Molina, D. M., Jafari, R., Ignatushchenko, M., Seki, T., Larsson, E. A., Dan, C., Sreekumar, L., Cao, Y., & Nordlund, P. (2013) · Science · doi:10.1126/science.1233606 · Cited by 2,261
Pertuzumab, Trastuzumab, and Docetaxel in HER2-Positive Metastatic Breast Cancer
Swain, S. M., Baselga, J., Kim, S.-B., Ro, J., Semiglazov, V., Campone, M., Ciruelos, E., Ferrero, J.-M., Schneeweiss, A., Heeson, S., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1413513 · Cited by 2,164
QSAR Modeling: Where have you been? Where are you going to?
Cherkasov, A., Muratov, E. N., Fourches, D., Varnek, A., Baskin, I. I., Cronin, M., Dearden, J., Gramatica, P., Martin, Y. C., Todeschini, R., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm4004285 · Cited by 2,164
Computational Methods in Drug Discovery
Sliwoski, G., Kothiwale, S., Meiler, J., & Lowe, E. W. (2014) · Pharmacological Reviews · doi:10.1124/pr.112.007336 · Cited by 2,160
Drug Discovery and Natural Products: End of an Era or an Endless Frontier?
Li, J. W.-H., & Vederas, J. C. (2009) · Science · doi:10.1126/science.1168243 · Cited by 2,052
Glioma Groups Based on 1p/19q,IDH, and TERT Promoter Mutations in Tumors
Eckel-Passow, J. E., Lachance, D. H., Molinaro, A. M., Walsh, K. M., Decker, P. A., Sicotte, H., Pekmezci, M., Rice, T., Kosel, M. L., Smirnov, I. V., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1407279 · Cited by 1,982
Nicholson, J. K., & Lindon, J. C. (2008) · Nature · doi:10.1038/4551054a · Cited by 1,886
Natural products in drug discovery
Harvey, A. L. (2008) · Drug Discovery Today · doi:10.1016/j.drudis.2008.07.004 · Cited by 1,832
The ChEMBL bioactivity database: an update
Bento, A. P., Gaulton, A., Hersey, A., Bellis, L. J., Chambers, J., Davies, M., Krüger, F. A., Light, Y., Mak, L., McGlinchey, S., et al. (2014) · Nucleic Acids Research · doi:10.1093/nar/gkt1031 · Cited by 1,492
The cellular thermal shift assay for evaluating drug target interactions in cells
Jafari, R., Almqvist, H., Axelsson, H., Ignatushchenko, M., Lundbäck, T., Nordlund, P., & Molina, D. M. (2014) · Nature Protocols · doi:10.1038/nprot.2014.138 · Cited by 1,474
The discovery of artemisinin (qinghaosu) and gifts from Chinese medicine
Tu, Y. (2011) · Nature Medicine · doi:10.1038/nm.2471 · Cited by 1,392
Crystal structure of the µ-opioid receptor bound to a morphinan antagonist
Manglik, A., Kruse, A. C., Kobilka, T. S., Thian, F. S., Mathiesen, J. M., Sunahara, R. K., Pardo, L., Weis, W. I., Kobilka, B. K., & Granier, S. (2012) · Nature · doi:10.1038/nature10954 · Cited by 1,356
A ‘Rule of Three’ for fragment-based lead discovery?
Congreve, M., Carr, R., Murray, C., & Jhoti, H. (2003) · Drug Discovery Today · doi:10.1016/s1359-6446(03)02831-9 · Cited by 1,354
Wang, L., Wu, Y., Deng, Y., Kim, B., Pierce, L., Krilov, G., Lupyan, D., Robinson, S., Dahlgren, M. K., Greenwood, J., et al. (2015) · Journal of the American Chemical Society · doi:10.1021/ja512751q · Cited by 1,313
Personal omics profiling reveals dynamic molecular and medical phenotypes
Chen, R., Mias, G. I., Li-Pook-Than, J., Jiang, L., Lam, H. Y. K., Chen, R., Miriami, E., Karczewski, K. J., Hariharan, M., Dewey, F. E., et al. (2012) · Cell · doi:10.1016/j.cell.2012.02.009 · Cited by 1,291
GeneHancer: genome-wide integration of enhancers and target genes in GeneCards
Fishilevich, S., Nudel, R., Rappaport, N., Hadar, R., Plaschkes, I., Iny Stein, T., Rosen, N., Kohn, A., Twik, M., Safran, M., et al. (2017) · Database · doi:10.1093/database/bax028 · Cited by 1,271
Counting on natural products for drug design
Rodrigues, T., Reker, D., Schneider, P., & Schneider, G. (2016) · Nature Chemistry · doi:10.1038/nchem.2479 · Cited by 1,250
Function-Oriented Synthesis, Step Economy, and Drug Design
Wender, P. A., Verma, V. A., Paxton, T. J., & Pillow, T. H. (2008) · Accounts of Chemical Research · doi:10.1021/ar700155p · Cited by 1,204
Tracking cancer drugs in living cells by thermal profiling of the proteome
Savitski, M. M., Reinhard, F. B. M., Franken, H., Werner, T., Savitski, M. F., Eberhard, D., Molina, D. M., Jafari, R., Dovega, R. B., Klaeger, S., et al. (2014) · Science · doi:10.1126/science.1255784 · Cited by 1,187 · cited 1×
“By identifying off-targets TPP can be used to study possible side effects of candidate drug compounds [150].”
BackgroundOrgans-on-chips at the frontiers of drug discovery
Esch, E. W., Bahinski, A., & Huh, D. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4539 · Cited by 1,185
PASS: prediction of activity spectra for biologically active substances
Lagunin, A., Stepanchikova, A., Filimonov, D., & Poroikov, V. (2000) · Bioinformatics · doi:10.1093/bioinformatics/16.8.747 · Cited by 1,161
Target identification and mechanism of action in chemical biology and drug discovery
Schenone, M., Dančík, V., Wagner, B. K., & Clemons, P. A. (2013) · Nature Chemical Biology · doi:10.1038/nchembio.1199 · Cited by 1,096
Target identification using drug affinity responsive target stability (DARTS)
Lomenick, B., Hao, R., Jonai, N., Chin, R. M., Aghajan, M., Warburton, S., Wang, J., Wu, R. P., Gomez, F., Loo, J. A., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0910040106 · Cited by 1,095
Swain, S. M., Kim, S.-B., Cortés, J., Ro, J., Semiglazov, V., Campone, M., Ciruelos, E., Ferrero, J.-M., Schneeweiss, A., Knott, A., et al. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70130-x · Cited by 1,006
The Connectivity Map: A new tool for biomedical research
Lamb, J. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2044 · Cited by 945
DNA methylation and healthy human aging
Jones, M. J., Goodman, S. J., & Kobor, M. S. (2015) · Aging Cell · doi:10.1111/acel.12349 · Cited by 928
Schneider, G. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.232 · Cited by 910 · cited 1×
“Several compounds based on the imidazopyridine scaffold have been synthesised using automated computer-assisted de novo design resulting in the discovery of many ligands for G protein-coupled receptors antagonists [213,235,236].”
MethodA practical recipe for stable isotope labeling by amino acids in cell culture (SILAC)
Ong, S.-E., & Mann, M. (2006) · Nature Protocols · doi:10.1038/nprot.2006.427 · Cited by 896
Trends in Risks Associated With New Drug Development: Success Rates for Investigational Drugs
DiMasi, J. A., Feldman, L., Seckler, A., & Wilson, A. (2010) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2009.295 · Cited by 845
Automated design of ligands to polypharmacological profiles
Besnard, J., Ruda, G. F., Setola, V., Abecassis, K., Rodriguiz, R. M., Huang, X.-P., Norval, S., Sassano, M. F., Shin, A. I., Webster, L. A., et al. (2012) · Nature · doi:10.1038/nature11691 · Cited by 832
An analysis of FDA-approved drugs: natural products and their derivatives
Patridge, E., Gareiss, P., Kinch, M. S., & Hoyer, D. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2015.01.009 · Cited by 831
Artemisinin—A Gift from Traditional Chinese Medicine to the World (Nobel Lecture)
Tu, Y. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201601967 · Cited by 810
Blunt, J. W., Carroll, A. R., Copp, B. R., Davis, R. A., Keyzers, R. A., & Prinsep, M. R. (2018) · Natural Product Reports · doi:10.1039/c7np00052a · Cited by 771
From machine learning to deep learning: progress in machine intelligence for rational drug discovery
Zhang, L., Tan, J., Han, D., & Zhu, H. (2017) · Drug Discovery Today · doi:10.1016/j.drudis.2017.08.010 · Cited by 760
Metabolomics: an emerging but powerful tool for precision medicine
Clish, C. B. (2015) · Molecular Case Studies · doi:10.1101/mcs.a000588 · Cited by 708
King, R. D., Rowland, J., Oliver, S. G., Young, M., Aubrey, W., Byrne, E., Liakata, M., Markham, M., Pir, P., Soldatova, L. N., et al. (2009) · Science · doi:10.1126/science.1165620 · Cited by 679
Defining Translational Research: Implications for Training
Rubio, D. M., Schoenbaum, E. E., Lee, L. S., Schteingart, D. E., Marantz, P. R., Anderson, K. E., Platt, L. D., Baez, A., & Esposito, K. (2010) · Academic Medicine · doi:10.1097/acm.0b013e3181ccd618 · Cited by 675
Franken, H., Mathieson, T., Childs, D., Sweetman, G. M. A., Werner, T., Tögel, I., Doce, C., Gade, S., Bantscheff, M., Drewes, G., et al. (2015) · Nature Protocols · doi:10.1038/nprot.2015.101 · Cited by 659
Joana Gil‐Chávez, G., Villa, J. A., Fernando Ayala‐Zavala, J., Basilio Heredia, J., Sepulveda, D., Yahia, E. M., & González‐Aguilar, G. A. (2013) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/1541-4337.12005 · Cited by 657
Computer‐Assisted Synthetic Planning: The End of the Beginning
Szymkuć, S., Gajewska, E. P., Klucznik, T., Molga, K., Dittwald, P., Startek, M., Bajczyk, M., & Grzybowski, B. A. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201506101 · Cited by 611
Özdemir, V., & Hekim, N. (2018) · OMICS: A Journal of Integrative Biology · doi:10.1089/omi.2017.0194 · Cited by 602
Target profiling of small molecules by chemical proteomics
Rix, U., & Superti-Furga, G. (2009) · Nature Chemical Biology · doi:10.1038/nchembio.216 · Cited by 575
Synthesis of many different types of organic small molecules using one automated process
Li, J., Ballmer, S. G., Gillis, E. P., Fujii, S., Schmidt, M. J., Palazzolo, A. M. E., Lehmann, J. W., Morehouse, G. F., & Burke, M. D. (2015) · Science · doi:10.1126/science.aaa5414 · Cited by 539
Wetzel, S., Bon, R. S., Kumar, K., & Waldmann, H. (2011) · Angewandte Chemie International Edition · doi:10.1002/anie.201007004 · Cited by 505
Predicting drug metabolism: experiment and/or computation?
Kirchmair, J., Göller, A. H., Lang, D., Kunze, J., Testa, B., Wilson, I. D., Glen, R. C., & Schneider, G. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4581 · Cited by 502
Demystifying traditional herbal medicine with modern approach
Li, F.-S., & Weng, J.-K. (2017) · Nature Plants · doi:10.1038/nplants.2017.109 · Cited by 498
Computational approaches to natural product discovery
Medema, M. H., & Fischbach, M. A. (2015) · Nature Chemical Biology · doi:10.1038/nchembio.1884 · Cited by 493
Genome-wide mapping of nucleosome positioning and DNA methylation within individual DNA molecules
Kelly, T. K., Liu, Y., Lay, F. D., Liang, G., Berman, B. P., & Jones, P. A. (2012) · Genome Research · doi:10.1101/gr.143008.112 · Cited by 455
Liu, X., & Locasale, J. W. (2017) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2017.01.004 · Cited by 453
Generative Recurrent Networks for De Novo Drug Design
Gupta, A., Müller, A. T., Huisman, B. J. H., Fuchs, J. A., Schneider, P., & Schneider, G. (2018) · Molecular Informatics · doi:10.1002/minf.201700111 · Cited by 441
The Rise of Chemodiversity in Plants
Weng, J.-K., Philippe, R. N., & Noel, J. P. (2012) · Science · doi:10.1126/science.1217411 · Cited by 428
Genome-wide signatures of differential DNA methylation in pediatric acute lymphoblastic leukemia
Nordlund, J., Bäcklin, C. L., Wahlberg, P., Busche, S., Berglund, E. C., Eloranta, M.-L., Flaegstad, T., Forestier, E., Frost, B.-M., Harila-Saari, A., et al. (2013) · Genome Biology · doi:10.1186/gb-2013-14-9-r105 · Cited by 378
Artemisinins Target GABAA Receptor Signaling and Impair α Cell Identity
Li, J., Casteels, T., Frogne, T., Ingvorsen, C., Honoré, C., Courtney, M., Huber, K. V. M., Schmitner, N., Kimmel, R. A., Romanov, R. A., et al. (2017) · Cell · doi:10.1016/j.cell.2016.11.010 · Cited by 376
De Novo Design of Bioactive Small Molecules by Artificial Intelligence
Merk, D., Friedrich, L., Grisoni, F., & Schneider, G. (2018) · Molecular Informatics · doi:10.1002/minf.201700153 · Cited by 373
A Systematic Mammalian Genetic Interaction Map Reveals Pathways Underlying Ricin Susceptibility
Bassik, M. C., Kampmann, M., Lebbink, R. J., Wang, S., Hein, M. Y., Poser, I., Weibezahn, J., Horlbeck, M. A., Chen, S., Mann, M., et al. (2013) · Cell · doi:10.1016/j.cell.2013.01.030 · Cited by 365 · cited 1×
“Recently clustered regularly interspaced short palindromic repeats-Cas9 (CRISPR-Cas9) genome editing approaches have been used to overcome off-target effects of candidate compounds and to delineate how many natural compounds work [155,156].”
Korotcov, A., Tkachenko, V., Russo, D. P., & Ekins, S. (2017) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.7b00578 · Cited by 352
Jing, Y., Bian, Y., Hu, Z., Wang, L., & Xie, X.-Q. S. (2018) · The AAPS Journal · doi:10.1208/s12248-018-0210-0 · Cited by 351
DNA barcoding: an efficient tool to overcome authentication challenges in the herbal market
Mishra, P., Kumar, A., Nagireddy, A., Mani, D. N., Shukla, A. K., Tiwari, R., & Sundaresan, V. (2016) · Plant Biotechnology Journal · doi:10.1111/pbi.12419 · Cited by 327
Thermal proteome profiling monitors ligand interactions with cellular membrane proteins
Reinhard, F. B. M., Eberhard, D., Werner, T., Franken, H., Childs, D., Doce, C., Savitski, M. F., Huber, W., Bantscheff, M., Savitski, M. M., et al. (2015) · Nature Methods · doi:10.1038/nmeth.3652 · Cited by 315
Identification of Direct Protein Targets of Small Molecules
Lomenick, B., Olsen, R. W., & Huang, J. (2011) · ACS Chemical Biology · doi:10.1021/cb100294v · Cited by 299
Flow Chemistry: Intelligent Processing of Gas–Liquid Transformations Using a Tube-in-Tube Reactor
Brzozowski, M., O’Brien, M., Ley, S. V., & Polyzos, A. (2015) · Accounts of Chemical Research · doi:10.1021/ar500359m · Cited by 294
A molecular barcoded yeast ORF library enables mode-of-action analysis of bioactive compounds
Ho, C. H., Magtanong, L., Barker, S. L., Gresham, D., Nishimura, S., Natarajan, P., Koh, J. L. Y., Porter, J., Gray, C. A., Andersen, R. J., et al. (2009) · Nature Biotechnology · doi:10.1038/nbt.1534 · Cited by 292
Geiger, T., Wisniewski, J. R., Cox, J., Zanivan, S., Kruger, M., Ishihama, Y., & Mann, M. (2011) · Nature Protocols · doi:10.1038/nprot.2010.192 · Cited by 281
Eldridge, G. R., Vervoort, H. C., Lee, C. M., Cremin, P. A., Williams, C. T., Hart, S. M., Goering, M. G., O'Neil-Johnso, M., & Zeng, L. (2002) · Analytical Chemistry · doi:10.1021/ac025534s · Cited by 258
Frontiers in cancer nanomedicine: directing mass transport through biological barriers
Ferrari, M. (2010) · Trends in Biotechnology · doi:10.1016/j.tibtech.2009.12.007 · Cited by 255
Thermal profiling reveals phenylalanine hydroxylase as an off-target of panobinostat
Becher, I., Werner, T., Doce, C., Zaal, E. A., Tögel, I., Khan, C. A., Rueger, A., Muelbaier, M., Salzer, E., Berkers, C. R., et al. (2016) · Nature Chemical Biology · doi:10.1038/nchembio.2185 · Cited by 251
Integrating virtual screening in lead discovery
Oprea, T. I., & Matter, H. (2004) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2004.06.008 · Cited by 250
Global medicinal uses of Euphorbia L. (Euphorbiaceae)
Ernst, M., Grace, O. M., Saslis‐Lagoudakis, C. H., Nilsson, N. E., Simonsen, H. T., & Rønsted, N. (2015) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2015.10.025 · Cited by 245
Bioactivity-Guided Navigation of Chemical Space
Bon, R. S., & Waldmann, H. (2010) · Accounts of Chemical Research · doi:10.1021/ar100014h · Cited by 245
Artificial Intelligence Approaches for Rational Drug Design and Discovery
Duch, W., Swaminathan, K., & Meller, J. (2007) · Current Pharmaceutical Design · doi:10.2174/138161207780765954 · Cited by 243
Treatment of Relapsed/Refractory Acute Myeloid Leukemia
Bose, P., Vachhani, P., & Cortes, J. E. (2017) · Current Treatment Options in Oncology · doi:10.1007/s11864-017-0456-2 · Cited by 240
West, G. M., Tang, L., & Fitzgerald, M. C. (2008) · Analytical Chemistry · doi:10.1021/ac702610a · Cited by 239
Meanwell, N. A. (2016) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.6b00043 · Cited by 239
A renaissance of neural networks in drug discovery
Baskin, I. I., Winkler, D., & Tetko, I. V. (2016) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2016.1201262 · Cited by 235
Development of artemisinin compounds for cancer treatment
Lai, H. C., Singh, N. P., & Sasaki, T. (2013) · Investigational New Drugs · doi:10.1007/s10637-012-9873-z · Cited by 233
Swain, S. M., Baselga, J., Miles, D., Im, Y.-H., Quah, C., Lee, L. F., & Cortés, J. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu133 · Cited by 232
Interactive exploration of chemical space with Scaffold Hunter
Wetzel, S., Klein, K., Renner, S., Rauh, D., Oprea, T. I., Mutzel, P., & Waldmann, H. (2009) · Nature Chemical Biology · doi:10.1038/nchembio.187 · Cited by 228
Reker, D., Rodrigues, T., Schneider, P., & Schneider, G. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1320001111 · Cited by 227
Scaffold diversity of natural products: inspiration for combinatorial library design
Grabowski, K., Baringhaus, K.-H., & Schneider, G. (2008) · Natural Product Reports · doi:10.1039/b715668p · Cited by 218
Xiao, X., Min, J.-L., Lin, W.-Z., Liu, Z., Cheng, X., & Chou, K.-C. (2015) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2014.998710 · Cited by 217
Authentication of medicinal plants by DNA markers
Ganie, S. H., Upadhyay, P., Das, S., & Prasad Sharma, M. (2015) · Plant Gene · doi:10.1016/j.plgene.2015.10.002 · Cited by 217
The quest for modernisation of traditional Chinese medicine
Xu, Q., Bauer, R., Hendry, B. M., Fan, T.-P., Zhao, Z., Duez, P., Simmonds, M. S., Witt, C. M., Lu, A., Robinson, N., et al. (2013) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-13-132 · Cited by 215
Proteome-wide drug and metabolite interaction mapping by thermal-stability profiling
Huber, K. V. M., Olek, K. M., Müller, A. C., Tan, C. S. H., Bennett, K. L., Colinge, J., & Superti-Furga, G. (2015) · Nature Methods · doi:10.1038/nmeth.3590 · Cited by 210
Reinvigorating natural product combinatorial biosynthesis with synthetic biology
Kim, E., Moore, B. S., & Yoon, Y. J. (2015) · Nature Chemical Biology · doi:10.1038/nchembio.1893 · Cited by 207
Clinical Approval Success Rates for Investigational Cancer Drugs
DiMasi, J. A., Reichert, J. M., Feldman, L., & Malins, A. (2013) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2013.117 · Cited by 203
Greene, C. S., Tan, J., Ung, M., Moore, J. H., & Cheng, C. (2014) · Journal of Cellular Physiology · doi:10.1002/jcp.24662 · Cited by 194
Chan, K., Shaw, D., Simmonds, M. S. J., Leon, C. J., Xu, Q., Lu, A., Sutherland, I., Ignatova, S., Zhu, Y.-P., Verpoorte, R., et al. (2012) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2012.01.038 · Cited by 191
Learning to Predict Chemical Reactions
Kayala, M. A., Azencott, C.-A., Chen, J. H., & Baldi, P. (2011) · Journal of Chemical Information and Modeling · doi:10.1021/ci200207y · Cited by 190
West, G. M., Tucker, C. L., Xu, T., Park, S. K., Han, X., Yates, J. R., & Fitzgerald, M. C. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1000148107 · Cited by 190
(−)‐Englerin A is a Potent and Selective Activator of TRPC4 and TRPC5 Calcium Channels
Akbulut, Y., Gaunt, H. J., Muraki, K., Ludlow, M. J., Amer, M. S., Bruns, A., Vasudev, N. S., Radtke, L., Willot, M., Hahn, S., et al. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201411511 · Cited by 190
Van Molle, I., Thomann, A., Buckley, D. L., So, E. C., Lang, S., Crews, C. M., & Ciulli, A. (2012) · Chemistry & Biology · doi:10.1016/j.chembiol.2012.08.015 · Cited by 188
Wen, M.-C., Wei, C.-H., Hu, Z.-Q., Srivastava, K., Ko, J., Xi, S.-T., Mu, D.-Z., Du, J.-B., Li, G.-H., Wallenstein, S., et al. (2005) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2005.05.029 · Cited by 187
Towards Robot Scientists for autonomous scientific discovery
Sparkes, A., Aubrey, W., Byrne, E., Clare, A., Khan, M. N., Liakata, M., Markham, M., Rowland, J., Soldatova, L. N., Whelan, K. E., et al. (2010) · Automated Experimentation · doi:10.1186/1759-4499-2-1 · Cited by 187
Predicting drug side effects by multi-label learning and ensemble learning
Zhang, W., Liu, F., Luo, L., & Zhang, J. (2015) · BMC Bioinformatics · doi:10.1186/s12859-015-0774-y · Cited by 187
Buriani, A., Garcia-Bermejo, M. L., Bosisio, E., Xu, Q., Li, H., Dong, X., Simmonds, M. S. J., Carrara, M., Tejedor, N., Lucio-Cazana, J., et al. (2012) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2012.01.055 · Cited by 184
Mass Spectrometry-Based Proteomics in Preclinical Drug Discovery
Schirle, M., Bantscheff, M., & Kuster, B. (2012) · Chemistry & Biology · doi:10.1016/j.chembiol.2012.01.002 · Cited by 180
Mateus, A., Määttä, T. A., & Savitski, M. M. (2016) · Proteome Science · doi:10.1186/s12953-017-0122-4 · Cited by 177
Genome‐wide DNA methylation changes with age in disease‐free human skeletal muscle
Zykovich, A., Hubbard, A., Flynn, J. M., Tarnopolsky, M., Fraga, M. F., Kerksick, C., Ogborn, D., MacNeil, L., Mooney, S. D., & Melov, S. (2014) · Aging Cell · doi:10.1111/acel.12180 · Cited by 176
Lai, H., & Singh, N. P. (2006) · Cancer Letters · doi:10.1016/j.canlet.2005.01.019 · Cited by 170
Ultra‐performance LC/TOF MS analysis of medicinal Panax herbs for metabolomic research
Xie, G., Plumb, R., Su, M., Xu, Z., Zhao, A., Qiu, M., Long, X., Liu, Z., & Jia, W. (2008) · Journal of Separation Science · doi:10.1002/jssc.200700650 · Cited by 169
Proteomic and Genetic Approaches Identify Syk as an AML Target
Hahn, C. K., Berchuck, J. E., Ross, K. N., Kakoza, R. M., Clauser, K., Schinzel, A. C., Ross, L., Galinsky, I., Davis, T. N., Silver, S. J., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.08.018 · Cited by 167
Design and synthesis of analogues of natural products
Maier, M. E. (2015) · Organic & Biomolecular Chemistry · doi:10.1039/c5ob00169b · Cited by 166
Identifying compound efficacy targets in phenotypic drug discovery
Schirle, M., & Jenkins, J. L. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2015.08.001 · Cited by 164
Chang, J., Kim, Y., & Kwon, H. J. (2016) · Natural Product Reports · doi:10.1039/c5np00107b · Cited by 162
Advances in targeted genome editing
Perez-Pinera, P., Ousterout, D. G., & Gersbach, C. A. (2012) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2012.06.007 · Cited by 159
McGovern, P. E., Mirzoian, A., & Hall, G. R. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0811578106 · Cited by 150
Skroza, D., Mekinić, I. G., Svilović, S., Šimat, V., & Katalinić, V. (2014) · Journal of Food Composition and Analysis · doi:10.1016/j.jfca.2014.06.013 · Cited by 149
Biology-inspired synthesis of compound libraries
Kaiser, M., Wetzel, S., Kumar, K., & Waldmann, H. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-7492-1 · Cited by 148
Sharma, G. D., Tyagi, A. K., Singh, R. P., Chan, D. C. F., & Agarwal, R. (2004) · Breast Cancer Research and Treatment · doi:10.1023/b:brea.0000020991.55659.59 · Cited by 147
Affinity monolith chromatography: a review of principles and recent analytical applications
Pfaunmiller, E. L., Paulemond, M. L., Dupper, C. M., & Hage, D. S. (2012) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-012-6568-4 · Cited by 147
Natural products and Pharma 2011: Strategic changes spur new opportunities
Carter, G. T. (2011) · Natural Product Reports · doi:10.1039/c1np00033k · Cited by 144
A proteomics approach to discovering natural products and their biosynthetic pathways
Bumpus, S. B., Evans, B. S., Thomas, P. M., Ntai, I., & Kelleher, N. L. (2009) · Nature Biotechnology · doi:10.1038/nbt.1565 · Cited by 143
Neggers, J. E., Vercruysse, T., Jacquemyn, M., Vanstreels, E., Baloglu, E., Shacham, S., Crochiere, M. L., Landesman, Y., & Daelemans, D. (2015) · Chemistry & Biology · doi:10.1016/j.chembiol.2014.11.015 · Cited by 142
Marine Natural Product Libraries for High-Throughput Screening and Rapid Drug Discovery
Bugni, T. S., Richards, B. T., Bhoite, L., Cimbora, D. M., Harper, M. K., & Ireland, C. M. (2008) · Journal of Natural Products · doi:10.1021/np800184g · Cited by 141
Bioactivity-guided mapping and navigation of chemical space
Renner, S., van Otterlo, W. A. L., Domínguez, M., Möcklinghoff, S., Hofmann, B., Wetzel, S., Schuffenhauer, A., Ertl, P., Oprea, T. I., Steinhilber, D., et al. (2009) · Nature Chemical Biology · doi:10.1038/nchembio.188 · Cited by 140
Parallel Optimization of Synthetic Pathways within the Network of Organic Chemistry
Kowalik, M., Gothard, C. M., Drews, A. M., Gothard, N. A., Weckiewicz, A., Fuller, P. E., Grzybowski, B. A., & Bishop, K. J. M. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201202209 · Cited by 134
Making a big thing of a small cell – recent advances in single cell analysis
Galler, K., Bräutigam, K., Große, C., Popp, J., & Neugebauer, U. (2014) · The Analyst · doi:10.1039/c3an01939j · Cited by 133
Systematic evaluation of connectivity map for disease indications
Cheng, J., Yang, L., Kumar, V. D., & Agarwal, P. (2014) · Genome Medicine · doi:10.1186/s13073-014-0095-1 · Cited by 131
DrugTargetSeqR: a genomics- and CRISPR-Cas9–based method to analyze drug targets
Kasap, C., Elemento, O., & Kapoor, T. M. (2014) · Nature Chemical Biology · doi:10.1038/nchembio.1551 · Cited by 129
Cancer-on-a-chip systems at the frontier of nanomedicine
Zhang, Y. S., Zhang, Y.-N., & Zhang, W. (2017) · Drug Discovery Today · doi:10.1016/j.drudis.2017.03.011 · Cited by 127
Godfrey, A. G., Masquelin, T., & Hemmerle, H. (2013) · Drug Discovery Today · doi:10.1016/j.drudis.2013.03.001 · Cited by 127
Methods for the Elucidation of Protein-Small Molecule Interactions
McFedries, A., Schwaid, A. G., & Saghatelian, A. (2013) · Chemistry & Biology · doi:10.1016/j.chembiol.2013.04.008 · Cited by 126
Thomford, N. E., Dzobo, K., Chopera, D., Wonkam, A., Skelton, M., Blackhurst, D., Chirikure, S., & Dandara, C. (2015) · Pharmaceuticals · doi:10.3390/ph8030637 · Cited by 125
Self-citationSaaby, S., Knudsen, K. R., Ladlow, M., & Ley, S. V. (2005) · Chemical Communications · doi:10.1039/b504854k · Cited by 123
Stable-isotope labeling with amino acids in nematodes
Larance, M., Bailly, A. P., Pourkarimi, E., Hay, R. T., Buchanan, G., Coulthurst, S., Xirodimas, D. P., Gartner, A., & Lamond, A. I. (2011) · Nature Methods · doi:10.1038/nmeth.1679 · Cited by 120
Genovino, J., Sameš, D., Hamann, L. G., & Touré, B. B. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201602644 · Cited by 120
The genetics of drug efficacy: opportunities and challenges
Nelson, M. R., Johnson, T., Warren, L. L., Hughes, A. R., Chissoe, S. L., Xu, C., & Waterworth, D. M. (2016) · Nature Reviews Genetics · doi:10.1038/nrg.2016.12 · Cited by 116
High impact technologies for natural products screening
Koehn, F. E. (2007) · Birkhäuser Basel eBooks · doi:10.1007/978-3-7643-8117-2_5 · Cited by 115
Lab automation and robotics: Automation on the move
Chapman, T. (2003) · Nature · doi:10.1038/421661a · Cited by 114
Omberg, L., Ellrott, K., Yuan, Y., Kandoth, C., Wong, C., Kellen, M., Friend, S. H., Stuart, J. M., Liang, H., & Margolin, A. A. (2013) · Nature Genetics · doi:10.1038/ng.2761 · Cited by 114
Biological networks and analysis of experimental data in drug discovery
Nikolsky, Y., Nikolskaya, T., & Bugrim, A. E. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03420-3 · Cited by 112
Basu, S., Ellinger, B., Rizzo, S., Deraeve, C., Schürmann, M., Preut, H., Arndt, H., & Waldmann, H. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1015269108 · Cited by 111
Traditional Mediterranean and European herbal medicines
Leonti, M., & Verpoorte, R. (2017) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2017.01.052 · Cited by 110
Wong, W. R., Oliver, A. G., & Linington, R. G. (2012) · Chemistry & Biology · doi:10.1016/j.chembiol.2012.09.014 · Cited by 108
Verma, M., Wright, G. L., Hanash, S., Gopal-Srivastava, R., & Srivastava, S. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb03870.x · Cited by 106
Connectivity Map-based discovery of parbendazole reveals targetable human osteogenic pathway
Brum, A. M., van de Peppel, J., van der Leije, C. S., Schreuders‐Koedam, M., Eijken, M., van der Eerden, B. C. J., & van Leeuwen, J. P. T. M. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1501597112 · Cited by 105
Lv, C., Wu, X., Wang, X., Su, J., Zeng, H., Zhao, J., Lin, S., Liu, R., Li, H., Li, X., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-00535-8 · Cited by 105
WAT-on-a-chip: a physiologically relevant microfluidic system incorporating white adipose tissue
Loskill, P., Thiagarajan, S., Tharp, K. M., Lee-Montiel, F. T., Jeeawoody, S., Reese, W. M., Zushin, P. H., Stahl, A., & Healy, K. E. (2017) · Lab on a Chip · doi:10.1039/c6lc01590e · Cited by 103
Current strategies for drug discovery through natural products
Harvey, A. L., Clark, R. L., Mackay, S. P., & Johnston, B. F. (2010) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2010.488263 · Cited by 102
Lao, Y., Wang, X., Xu, N., et al. (2014) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2014.05.022 · Cited by 101
Identifying targets for drug discovery using bioinformatics
Chen, Y. P., & Chen, F. (2008) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.12.4.383 · Cited by 99
The Proximal Lilly Collection: Mapping, Exploring and Exploiting Feasible Chemical Space
Nicolaou, C. A., Watson, I. A., Hu, H., & Wang, J. (2016) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.6b00173 · Cited by 99
The Impact of Genomics on Drug Discovery
Debouck, C., & Metcalf, B. (2000) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.40.1.193 · Cited by 96
An Integrated Microfluidic Processor for DNA-Encoded Combinatorial Library Functional Screening
MacConnell, A. B., Price, A. K., & Paegel, B. M. (2017) · ACS Combinatorial Science · doi:10.1021/acscombsci.6b00192 · Cited by 96
Genome-wide analysis of DNA methylation in bovine placentas
Su, J., Wang, Y., Xing, X., Liu, J., & Zhang, Y. (2014) · BMC Genomics · doi:10.1186/1471-2164-15-12 · Cited by 95
Kiyohara, H., Matsumoto, T., & Yamada, H. (2004) · Evidence-based Complementary and Alternative Medicine · doi:10.1093/ecam/neh004 · Cited by 95
Preparative Microfluidic Electrosynthesis of Drug Metabolites
Stalder, R., & Roth, G. P. (2013) · ACS Medicinal Chemistry Letters · doi:10.1021/ml400316p · Cited by 91
Multi‐Objective Molecular De Novo Design by Adaptive Fragment Prioritization
Reutlinger, M., Rodrigues, T., Schneider, P., & Schneider, G. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201310864 · Cited by 89
Eyer, K., Stratz, S., Kuhn, P., Küster, S. K., & Dittrich, P. S. (2013) · Analytical Chemistry · doi:10.1021/ac303628j · Cited by 88
DeArmond, P. D., Xu, Y., Strickland, E. C., Daniels, K. G., & Fitzgerald, M. C. (2011) · Journal of Proteome Research · doi:10.1021/pr200403c · Cited by 86
Integrated Platform for Expedited Synthesis–Purification–Testing of Small Molecule Libraries
Baranczak, A., Tu, N. P., Marjanovic, J., Searle, P. A., Vasudevan, A., & Djurić, S. W. (2017) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.7b00054 · Cited by 83
Antidiabetic Effects of Aronia melanocarpa and Its Other Therapeutic Properties
Banjari, I., Misir, A., Šavikin, K., Jokić, S., Molnar, M., Zoysa, H. K. S. D., & Waisundara, V. Y. (2017) · Frontiers in Nutrition · doi:10.3389/fnut.2017.00053 · Cited by 80
Drug Discovery Goes Three-Dimensional: Goodbye to Flat High-Throughput Screening?
Eglen, R. M., & Randle, D. H. (2015) · Assay and Drug Development Technologies · doi:10.1089/adt.2015.647 · Cited by 79
Hofstetter, R. K., Fassauer, G. M., & Link, A. (2018) · Journal of Chromatography B · doi:10.1016/j.jchromb.2018.01.024 · Cited by 77
Challenges and Opportunities in Developing Novel Drugs for TB
Kaneko, T., Cooper, C. B., & Mdluli, K. E. (2011) · Future Medicinal Chemistry · doi:10.4155/fmc.11.115 · Cited by 74
Function through Synthesis-Informed Design
Wender, P. A., Quiroz, R. V., & Stevens, M. C. (2015) · Accounts of Chemical Research · doi:10.1021/acs.accounts.5b00004 · Cited by 74
Vogelsang, M., Wang, Y., Veber, N., Mwapagha, L. M., & Parker, M. I. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036962 · Cited by 73
Real world big data for clinical research and drug development
Singh, G., Schulthess, D. G., Hughes, N., Vannieuwenhuyse, B., & Kalra, D. (2017) · Drug Discovery Today · doi:10.1016/j.drudis.2017.12.002 · Cited by 71
Lum, J. H., Fung, K.-L., Cheung, P., Wong, M., Lee, C., Kwok, F., Leung, M. C. P., Hui, P., & Lo, S. C. (2002) · PROTEOMICS · Cited by 70
Hung, M., Zhang, Z. J., Li, S., Lei, B., Yuan, S., Cui, G., Hoi, M. P. M., Chan, K., & Lee, S. M. (2012) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2012/605303 · Cited by 68
Reutlinger, M., Rodrigues, T., Schneider, P., & Schneider, G. (2013) · Angewandte Chemie International Edition · doi:10.1002/anie.201307786 · Cited by 68
Target identification for biologically active small molecules using chemical biology approaches
Lee, H., & Lee, J. W. (2016) · Archives of Pharmacal Research · doi:10.1007/s12272-016-0791-z · Cited by 67
The ENCODE Project and Perspectives on Pathways
Tragante, V., Moore, J. H., & Asselbergs, F. W. (2014) · Genetic Epidemiology · doi:10.1002/gepi.21802 · Cited by 65
Artificial Neural Networks: Theoretical Background and Pharmaceutical Applications: A Review
Wesołowski, M., & Suchacz, B. (2012) · Journal of AOAC International · doi:10.5740/jaoacint.sge_wesolowski_ann · Cited by 65
Park, H., In, G., Kim, J., Cho, B.-G., Han, G.-H., & Chang, I. (2014) · Journal of Ginseng Research · doi:10.1016/j.jgr.2013.11.011 · Cited by 63
Big Data and Analytics in Healthcare
Gao, G. G., Koch, S., & Tan, S. (2015) · Methods of Information in Medicine · doi:10.3414/me15-06-1001 · Cited by 63
Beneficial health applications and medicinal values of Pedicularis plants: A review
Yatoo, M. I., Dimri, U., Gopalakrishnan, A., Karthik, K., Gopi, M., Khandia, R., Saminathan, M., Saxena, A., Alagawany, M. M., Farag, M. R., et al. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.09.041 · Cited by 63
Nanomolar Inhibitors of the Transcription Factor STAT5b with High Selectivity over STAT5a
Elumalai, N., Berg, A., Natarajan, K., Scharow, A., & Berg, T. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201410672 · Cited by 62
Authentication of Eleutherococcus and Rhodiola herbal supplement products in the United Kingdom
Ruhsam, M., & Hollingsworth, P. M. (2017) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2017.11.025 · Cited by 62
Target deconvolution of bioactive small molecules: the heart of chemical biology and drug discovery
Jung, H. J., & Kwon, H. J. (2015) · Archives of Pharmacal Research · doi:10.1007/s12272-015-0618-3 · Cited by 60
Dzobo, K., Senthebane, D. A., Rowe, A., Thomford, N. E., Mwapagha, L. M., Al-Awwad, N., Dandara, C., & Parker, M. I. (2016) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2016.0152 · Cited by 59
Self-citationTran, D. T., Adhikari, J., & Fitzgerald, M. C. (2014) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m113.034702 · Cited by 58
Chemical Space: Big Data Challenge for Molecular Diversity
Awale, M., Visini, R., Probst, D., Arús‐Pous, J., & Reymond, J. (2017) · CHIMIA International Journal for Chemistry · doi:10.2533/chimia.2017.661 · Cited by 57
The Influence of Big (Clinical) Data and Genomics on Precision Medicine and Drug Development
Denny, J. C., Driest, S. L. V., Wei, W., & Roden, D. M. (2017) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.951 · Cited by 56
Dzobo, K., Senthebane, D. A., Thomford, N. E., Rowe, A., Dandara, C., & Parker, M. I. (2018) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2017.0174 · Cited by 55
Self-citationMolecular Farming in Artemisia annua, a Promising Approach to Improve Anti-malarial Drug Production
Pulice, G., Pelaz, S., & Matías-Hernández, L. (2016) · Frontiers in Plant Science · doi:10.3389/fpls.2016.00329 · Cited by 53
Lee, K., Lo, H.-L., Tang, W.-C., Hsiao, H. H.-Y., & Yang, P. (2014) · Scientific Reports · doi:10.1038/srep06394 · Cited by 52
Zuegg, J., & Cooper, M. A. (2012) · Current Topics in Medicinal Chemistry · doi:10.2174/156802612802652466 · Cited by 52
The role of proteomics in progressing insights into plant secondary metabolism
Martínez‐Esteso, M. J., Martínez‐Márquez, A., Sellés‐Marchart, S., Carriel, J. M., & Bru‐Martínez, R. (2015) · Frontiers in Plant Science · doi:10.3389/fpls.2015.00504 · Cited by 51
Devillers, J. (2012) · Methods in molecular biology · doi:10.1007/978-1-62703-059-5_1 · Cited by 50
Towards Global QSAR Model Building for Acute Toxicity: Munro Database Case Study
Chavan, S., Nicholls, I. A., Karlsson, B., Rosengren, A. M., Ballabio, D., Consonni, V., & Todeschini, R. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms151018162 · Cited by 45
Cited by
Molecular Docking: Shifting Paradigms in Drug Discovery
Pinzi, L., & Rastelli, G. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20184331 · Cited by 2,344
Plant-Derived Natural Products: A Source for Drug Discovery and Development
Chaachouay, N., & Zidane, L. (2024) · Drugs and Drug Candidates · doi:10.3390/ddc3010011 · Cited by 1,081
Ginwala, R., Bhavsar, R., Chigbu, D. G. I., Jain, P., & Khan, Z. K. (2019) · Antioxidants · doi:10.3390/antiox8020035 · Cited by 588
Pharmacological potential of ginseng and its major component ginsenosides
Ratan, Z. A., Haidere, M. F., Hong, Y. H., Park, S. H., Lee, J.-O., Lee, J., & Cho, J. Y. (2021) · Journal of Ginseng Research · doi:10.1016/j.jgr.2020.02.004 · Cited by 543
Plant-Derived Anticancer Compounds as New Perspectives in Drug Discovery and Alternative Therapy
Dehelean, C. A., Marcovici, I., Soica, C., Mioc, M., Coricovac, D., Iurciuc, S., Cretu, O. M., & Pinzaru, I. (2021) · Molecules · doi:10.3390/molecules26041109 · Cited by 502
Metadata
- Authors
- Thomford, N. E., Senthebane, D. A., Rowe, A., Munro, D., Seele, P., Maroyi, A., & Dzobo, K.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2018-05-25
- Volume
- 19
- Issue
- 6
- Pages
- 1578
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W2803627340
- Cited by
- 1,241
- References
- 262
- FWCI
- 69.77
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.